BCOR mutations define a therapeutic vulnerability to DHODH Inhibition in acute myeloid leukemia.

brequinar (DUP 785) - BMS, Clear Creek Bio

leflunomide - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/41549155

Andrea Degasperi; Cherif Badja; Florian Robert; Gene Cc Koh; George Vassiliou; Jyoti Choudhary; Malgorzata Gozdecka; Serena Nik-Zainal; Sophie Momen; Soraya Boushaki; Theodoros I Roumeliotis; Yasin Memari; Zuza Kozik

Jan 19, 2026